Loading...
| A02620 | Pages: NA | Feb 2022 | 6603 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Medical Marijuana Market
Request Now !Marijuana refers to the dried leaves, flowers, stems, and seeds from the hemp plantCannabis sativa. There are 2 main active chemicals in Marijuanacannabidiol (CBD) and tetrahydocannabinol (THC), which impact the brain and relieve the pain, respectively. Marijuana provides pain relief in conditions such as fibromyalgia, grand mal seizures, and other medical conditions. Similarly, it reduces symptoms of many serious medical conditions such as AIDS, cancer, and glaucoma.
The increase in prevalence of diseases and growth in demand for relieving pain in conditions such as cancer, AIDS, seizures, and other diseases majorly drive the medical marijuana market. In 2016, countries such as Colombia, Macedonia, Israel, Germany, Australia, and others allowed the medical use of marijuana.
Thus, rise in number of countries legalizing the use of medical marijuana is anticipated to fuel the growth of the market during the forecast period. Furthermore, the stringent rules and regulations associated with the medical marijuana such as Medical Marijuana Regulation and Safety Act and increase in number of license issued every year stipulates demand of Marijuana in market.
Moreover, growth in investment in R&D and increase in business strategies by companies of marijuana is expected to impel the market growth. For instance, in 2016, Gibraltar Industries acquired Nexus Corporation strengthening its position as greenhouse manufacturer and distributor. However, complex regulatory framework to obtain license majorly hinders the medical marijuana market.
The market is segmented on the basis of medical application and geography. By medical applications, the market is categorized into chronic pain, migraine, cancer, arthritis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 MEDICAL MARIJUANA MARKET, BY MEDICAL APPLICATION
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. CHRONIC PAIN
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. MIGRAINE
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. CANCER
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. ARTHRITIS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. OTHERS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
CHAPTER 5 MEDICAL MARIJUANA MARKET, BY GEOGRAPHY
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.2.4. North America Medical Marijuana Market by Medical Application
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. Spain market size and forecast
5.3.3.3. Italy market size and forecast
5.3.3.4. Netherlands market size and forecast
5.3.3.5. Russia market size and forecast
5.3.3.6. Switzerland market size and forecast
5.3.3.7. Rest of Europe market size and forecast
5.3.4. Europe Medical Marijuana Market by Medical Application
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. India market size and forecast
5.4.3.2. Australia market size and forecast
5.4.3.3. Rest of Asia-Pacific market size and forecast
5.4.4. Asia-Pacific Medical Marijuana Market by Medical Application
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. South Africa market size and forecast
5.5.3.2. Chile market size and forecast
5.5.3.3. Columbia market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. Turkey market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast
5.5.4. LAMEA Medical Marijuana Market by Medical Application
CHAPTER 6 COMPANY PROFILES
6.1. CARA THERAPEUTICS INC.
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. CANOPY GROWTH
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. INSYS THERAPEUTICS
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. CANNAGROW HOLDINGS, INC.
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. CANNABIS SATIVA, INC.
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. ARENA PHARMACEUTICALS
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. APHRIA
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. GW PHARMACEUTICALS, PLC
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. LEXARIA CORP
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. INTERNATIONAL CONSOLIDATED COMPANIES, INC.
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
